Thousands of apartments have been added — and hundreds taken away — from Greater Philadelphia's pipeline in recent weeks, ...

European stocks closed broadly higher on Tuesday with investors largely making cautious moves, digesting mixed earnings updates and ...

Primark owner Associated British Foods saw shares climb after it saw ... Hikma Pharmaceuticals, down 36p to 1,820p, GSK, down ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...

GSK has filed a pair of lawsuits against Moderna, claiming infringement of patents covering mRNA vaccines for COVID-19 and respiratory syncytial virus (RSV). According to court documents, the ...

Emma Walmsley, CEO of GSK leading the keynote at the FT Live Global Pharma and Biotech Summit in London. Credit: Jenna Philpott / GlobalData. Following Donald Trump’s re-election as the 47 th ...

Teva Pharmaceutical Industries Ltd. ADR-2.23% $19.91B ...

The "Cosmetics Industry in South Africa" report has been added to ResearchAndMarkets.com's offering. South Africa's cosmetic industry, the largest cosmetics and personal care products market in Africa ...

As of November 08, 2024, GSK plc had a $73.1 billion market capitalization, putting it in the 96th percentile of companies in the Pharmaceuticals industry. Currently, GSK plc’s price-earnings ratio is ...